3Levy S, Camm AJ, Saksena S, et al. International consensus on Nomenelature and Classification of Atrial Fibrilation : A collaborative project of the working group on arrhythmias and the working group of cardiac pacing of the euroupan society of cardiology and the north American society of pacing and electrophysiology [ J ]. J Cardiovascular Electrophysiology, 2003,14:443 - 445.
5Lopaschuk GP, Kozak R. Trimetazidine inhibits fatty acid oxidation in the heart [J ]. J Mol Cell Cardiol, 1998, 30 : 112 - 116.
6Kantor PF, Lucien A, Kozak R, et al. The antianginal drug trimetazidine shifts cardiac energy metabolism from fatty acid oxidation to glucose oxidation by inhibiting mitochondrial long - chain 3 -ketoacyl conzyme A thiolase[ J ]. Cite Res, 2000, 86:580 - 588.
7Allibardi S, Chierchia SL, Margonato V,et al. Effects of trimetazidine on metabolic and functional recovery of postischemic rat hearts [ J ]. Cardiovasc Drugs Ther, 1998, 12:543 - 549.
8Knight C, Fox K. From antianginal drugs to myocardial cytoprotective agents[J]. Am J Cardiolol, 1995, 24:4 -7.
9Lewandowskl ED, Johnstion D, Roberts R. Effects of inoslne on glycolysis and contracture during myocardial ischemia [ J ]. Circ Res, 1991, 68:578 -587.
